BCIQ Profiles

Company Profile Report

Promethera's HepaStem cell therapy safe in liver failure study

Promethera said its HepaStem cell therapy comprising human adult liver-derived mesenchymal stem cells achieved a positive

Read the full 167 word article

How to gain access

Continue reading with a
two-week free trial.